Please enable JS

Investors & Media

SEC Filings

Form S-8
CRISPR THERAPEUTICS AG filed this Form S-8 on 06/01/2018
Document Outline
Entire Document (303.8 KB)
Subdocument 1 - S-8 - FORM S-8
Page 1 - As filed with the Securities and Exchange Commission on June 1, 2018
Page 2 - Part I
Page 3 - N/A
Page 4 - N/A
Page 5 - SIGNATURES
Subdocument 2 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - N/A
Page 3 - N/A
Subdocument 3 - EX-23.1 - EX-23.1
Page 1 - N/A
Subdocument 4 - EX-23.2 - EX-23.2
Page 1 - N/A
Subdocument 5 - EX-99.1 - EX-99.1
Page 1 - Exhibit 99.1
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - an Award is made, that the Administrator determines to be necessary or advisable to obtain approval
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Subdocument 6 - EX-99.2 - EX-99.2
Page 1 - Exhibit 99.2
Page 2 - N/A
Page 3 - that the Optionee shall be dismissed as a result of (i) any material breach by the Optionee of any a
Page 4 - N/A
Page 5 - N/A
Subdocument 7 - EX-99.3 - EX-99.3
Page 1 - Exhibit 99.3
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Subdocument 8 - EX-99.4 - EX-99.4
Page 1 - Exhibit 99.4
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Subdocument 9 - EX-99.5 - EX-99.5
Page 1 - Exhibit 99.5
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Subdocument 10 - EX-99.6 - EX-99.6
Page 1 - Exhibit 99.6
Page 2 - N/A
Page 3 - N/A
Subdocument 11 - EX-99.7 - EX-99.7
Page 1 - Exhibit 99.7
Page 2 - N/A
Page 3 - N/A
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet